Basic info
Industry
biotechnology research
Sectors
Biotechnology
IL17A / F
#IL17
Immunotherapy
#MLTX
partnering
#PsA
inflammatory skin & joint diseases
#Nanobody
#HS
Date founded
2021
Funding rounds raised
Total raised
$115M
from 6 investors over 6 rounds
M
MoonLake Immunotherapeutics AG raised $115M on April 6, 2022
Investors: RTW Investments, LP, Asymmetry Capital Management, L.P., Surveyor Capital, Tekla Capital Management and Monashee Investment Management LLC
M
MoonLake Immunotherapeutics AG raised undisclosed on May 11, 2021
Investors: Merck KGaA, Darmstadt, Germany